These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11234177)

  • 21. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Dec; 65(239):77497-9. PubMed ID: 11503726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytapheresis practice: recommendations of New York Cytapheresis Task Force.
    Kalter RD; Levine M; Pindyck J; Reich L; Reiss R; Spivack M; Sussman L; Wenz B
    N Y State J Med; 1982 Oct; 82(11):1597-1600. PubMed ID: 6959013
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA recommends screening blood for HTLV-I antibodies.
    Oncology (Williston Park); 1989 May; 3(5):69. PubMed ID: 2491449
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood banking: controls constrict sources.
    Phillips DF
    Hospitals; 1972 Dec; 46(24):41-4. PubMed ID: 4641824
    [No Abstract]   [Full Text] [Related]  

  • 25. Tissue oversight in hospitals: the role of the transfusion services.
    Hillyer CD; Josephson CD
    Transfusion; 2007 Feb; 47(2):185-7. PubMed ID: 17302760
    [No Abstract]   [Full Text] [Related]  

  • 26. Making blood money safe and respectable.
    White R
    FDA Consum; 1975 Dec-1976 Jan; 9(10):11-9. PubMed ID: 10305009
    [No Abstract]   [Full Text] [Related]  

  • 27. Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jun; 66(112):31146-65. PubMed ID: 11725786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical device software regulation: an industry perspective.
    Simons D
    Food Drug Law J; 1997; 52(2):189-92. PubMed ID: 10557558
    [No Abstract]   [Full Text] [Related]  

  • 29. Extended platelet storage makes a welcome difference.
    Townsend L
    MLO Med Lab Obs; 2007 Jun; 39(6):40-1. PubMed ID: 17691706
    [No Abstract]   [Full Text] [Related]  

  • 30. Blood product recalls in the United States.
    McCullough J; Riley E; Lindgren B; Pulkrabek S; Hall R; Riley W
    Transfusion; 2014 Sep; 54(9):2276-82. PubMed ID: 24863173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA NPRM would standardize blood labeling to permit inventory automation.
    McNeal BM
    Health Law Vigil; 1980 Dec; 3(24):6-7. PubMed ID: 10248995
    [No Abstract]   [Full Text] [Related]  

  • 32. Pressure grows over US blood ban.
    Goodman S
    Nature; 2001 Aug; 412(6846):467. PubMed ID: 11484010
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA & clinical software vendors: a line in the sand?
    Schneider P
    Healthc Inform; 1996 Jun; 13(6):100-2, 104, 106. PubMed ID: 10161397
    [No Abstract]   [Full Text] [Related]  

  • 34. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marginal recruitment impact of potential alterations to FDA deferral criteria for men who have sex with men.
    Spencer B; Rios J; Cable R
    Transfusion; 2006 May; 46(5):869-70; author reply 870. PubMed ID: 16686858
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA issues new rule on tissue safety.
    OR Manager; 2005 Jan; 21(1):5. PubMed ID: 15707142
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
    James JS
    AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gen-Probe, Chiron and US Red Cross to investigate new technology to provide an extra layer of safety to the blood supply.
    Front Med Biol Eng; 1999; 9(1):96-8. PubMed ID: 10354914
    [No Abstract]   [Full Text] [Related]  

  • 39. Public's confidence in blood supply's safety grows--study.
    Tokarski C
    Mod Healthc; 1989 Aug; 19(34):30. PubMed ID: 10294507
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA accuses Red Cross of unsafe practices. Inspections at embattled blood bank turn up 'serious' violations.
    Becker C
    Mod Healthc; 2001 Dec; 31(51):10. PubMed ID: 11820197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.